Abdominal aortic aneurysms arise from chronic, irreversible destruction of connective tissue. A promising pharmacologic approach not only suppresses development of aneurysms, but also induces regression (pages 1330–1338).
References
Thompson, R.W., Geraghty, P.J. & Lee, J.K. Curr. Prob. Surg. 39, 93–232 (2002).
Yoshimura, K. et al. Nat. Med. 11, 1330–1338 (2005).
The UK Small Aneurysm Trial Participants. Lancet 352, 1649–1655 (1998).
Lederle, F.A. et al. N. Engl. J. Med. 346, 1437–1444 (2002).
Wassef, M. et al. J. Vasc. Surg. 34, 730–738 (2001).
Pyo, R. et al. J. Clin. Invest. 105, 1641–1649 (2000).
Longo, G.M. et al. J. Clin. Invest. 110, 625–632 (2002).
Manning, M.W., Cassis, L.A. & Daugherty, A. Arterioscler. Thromb. Vasc. Biol. 23, 483–488 (2003).
Mosorin, M. et al. J. Vasc. Surg. 34, 606–610 (2001).
Baxter, B.T. et al. J. Vasc. Surg. 36, 1–12 (2002).
Han, Z. et al. J. Clin. Invest. 108, 73–81 (2001).
Matsumura, J.S., Pearce, W.H., McCarthy, W.J. & Yao, J.S. J. Vasc. Surg. 25, 113–123 (1997).
Allaire, E. et al. Ann. Surg. 239, 417–427 (2004).
Zarins, C.K. et al. Eur. J. Vasc. Endovasc. Surg. 29, 496–503 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thompson, R. Aneurysm treatments expand. Nat Med 11, 1279–1281 (2005). https://doi.org/10.1038/nm1205-1279
Issue Date:
DOI: https://doi.org/10.1038/nm1205-1279
- Springer Nature America, Inc.